title: [Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma].
authors.affiliation: Abteilung für Klinische Biochemie, Bengbu Medizinische Institut.
authors.forename: H B
authors.initials: HB
authors.lastname: Guo
authors.forename: B
authors.initials: B
authors.lastname: Stoffel-Wagner
authors.forename: W
authors.initials: W
authors.lastname: Brennemann
authors.forename: W
authors.initials: W
authors.lastname: Springer
authors.forename: D
authors.initials: D
authors.lastname: Klingmüller
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000097:blood*; D001859:Bone Neoplasms / Q000556:secondary; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000201:enzymology* / Q000556:secondary*; D008875:Middle Aged; D010751:Phosphopyruvate Hydratase / Q000097:blood*; D012189:Retrospective Studies; D012878:Skin Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D010751:Phosphopyruvate Hydratase
vernacular_title: Neuronspezifische Enolase (NSE): ein Serummarker der klinischen Progression für maligne metastasierte Melanome.